Adaptive immunity is required for durable responses to alectinib in murine models of EML4-ALK lung cancer
Raphael A. Nemenoff(University of Colorado Anschutz Medical Campus), Lynn E. Heasley(University of Colorado Health)
Cited by 0
Related Papers
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
|Oncogenesis|2013|256
Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression
|PLoS ONE|2010|145
Differential Gene Regulation by Specific Gain-of-function JNK1 Proteins Expressed in Swiss 3T3 Fibroblasts
|Journal of Biological Chemistry|2002|48
Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti–PD-1 response in NSCLC
|Life Science Alliance|2019|48